Clinical Trial Update: Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure [Phase 1, Phase 2]

View source ↗

Summary

A crossover pharmacokinetic and bioavailability study comparing subcutaneous versus intravenous administration of a novel furosemide regimen in subjects with ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Furosemide (novel regimen) (furosemide)

Snippet

Sponsor: SQ Innovation, Inc. | Conditions: Heart Failure | Phase 1, Phase 2 | Status: COMPLETED